ERLOTINIB 100 mg/1 (Erlotinib TABLET, FILM COATED) 100 mg/1

Erlotinib 100 mg tablets are a targeted therapy used to treat certain types of cancer. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Strength

100 mg/1

Pack Size

1 BOTTLE in 1 CARTON (31722-264-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erlotinib is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Erlotinib is often prescribed as part of a comprehensive cancer treatment plan.

Side Effects

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some individuals may also experience appetite loss, nausea, or shortness of breath. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

Erlotinib should be handled with care, especially by pregnant women or those planning to become pregnant, as it may cause harm to a developing fetus. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication.

Avoid Interactions

Erlotinib may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, smoking can reduce the effectiveness of Erlotinib.

Frequently Asked Questions

Erlotinib is used to treat certain types of cancer, including non-small cell lung cancer and pancreatic cancer, by targeting specific proteins that contribute to cancer cell growth.

Erlotinib is taken orally, typically once daily, and should be administered as prescribed by a healthcare professional.

Common side effects of Erlotinib include skin rash, diarrhea, fatigue, appetite loss, nausea, and shortness of breath.

Erlotinib may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Erlotinib may cause harm to a developing fetus and should be used with caution during pregnancy. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.